Abstract:Dominant cell type of neointima exhibited myofibroblast features and arose primarily from tissue external to the vein. Among differentially expressed genes identified by spatial transcriptomics, Fhl1 was strongly expressed in neointima. Fhl1 prevented NIH in vivo and cultured human veins through its anti‐inflammation and anti‐proliferation properties. Background Vein grafts are commonly employed in revascularisation surgery for multivessel coronary artery disease, yet neointimal hyperplasia (NIH) remains a critical impediment to the long‐term patency of these grafts. Despite this, effective methods to precisely identify and target interventions for the neointima are still inadequate. Methods In this study, Sprague–Dawley (SD) rats were used to establish an external jugular vein transplantation model, and the NIH pathophysiological process was tracked across 11 time points (0–35 days) using various histological stains. Spatial transcriptomics was performed on normal veins and 19‐day grafts to explore gene expression in neointimal regions. Immunohistochemical analysis identified neointima‐specific markers, while NIH progression was assessed in SD rats with four and a half LIM domains protein 1 (Fhl1) knockout and in human saphenous veins (HSV) with adenovirus‐mediated Fhl1 overexpression. Results Typical neointimal formation commenced by day 11 postgrafting and peaked at day 19. Neointimal cells originated from newly generated α‐SMA(+) repair cells located outside the grafted vein, displaying a hybrid fibroblast‐smooth muscle cell phenotype. Spatial transcriptomics identified stable and sustained Fhl1 expression within the neointima throughout the entire NIH phase. Systemic knockout of Fhl1 in SD rats via the phosphoinositide 3‐kinase pathway exacerbated graft inflammation, heightened cell proliferation, and accelerated NIH. Conversely, FHL1 overexpression in cultured HSV suppressed NIH. Conclusion These findings indicate that, following grafting into the arterial system, the newly formed repair cells external to the grafted vein play a pivotal role in NIH, with neointimal cells exhibiting stable and continuous Fhl1 expression. Fhl1 serves as a protective factor against NIH both in vivo and in HSV, likely due to its anti‐inflammatory and anti‐proliferative effects. Key points This study firstly used spatial transcriptomics technique to analyse the neointima and generated a specific neointimal transcriptomic atlas. Fhl1 exhibits specific and stable expression in the spatial region of the neointima. It has thus far the highest enrichment of expression in the neointima in NIH phases, suggesting that it is a prominent molecular biomarker of neointima. We generated rats with a Fhl1 deletion and found that insufficient Fhl1 expression caused an increase in the severity of vascular inflammation and proliferation during neointimal hyperplasia. Adenovirus‐mediated FHL1 overexpression in human saphenous vein have beneficial effects in preventing neointimal hyperplasia. These highlight its potential as a therapeutic target for mitigating vein graft failure associated with cardiovascular procedures. Spatial transcriptomics profiles and morphological observations demonstrated that a newly generated cell population outside the grafted vein with hybrid phenotype between SMCs and fibroblasts contributes to neointimal formation.

A Preliminary Study of FHL1 in Pathogenesis of Thoracic Aortic Aneurysm

Cyclic RNA hsa‑circ‑000595 regulates apoptosis of aortic smooth muscle cells

Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.

Expression of interferon-gamma in type Ⅰ thoracic aortic dissections and ascending thoracic aortic aneurysms

Effects of COL1A1 and SYTL2 on inflammatory cell infiltration and poor extracellular matrix remodeling of the vascular wall in thoracic aortic aneurysm

Fhl1, a new spatially specific protein, regulates vein graft neointimal hyperplasia

LINC02015 Modulates the Cell Proliferation and Apoptosis of Aortic Vascular Smooth Muscle Cells by Transcriptional Regulation and Protein Interaction Network.

FHL1 Inhibits the Progression of Colorectal Cancer by Regulating the Wnt/β-Catenin Signaling Pathway

Fas/FasL and Bronchial Asthma

Unlocking the secrets of Cardiac development and function: the critical role of FHL2

LncRNA H19 Regulates Proliferation, Apoptosis and ECM Degradation of Aortic Smooth Muscle Cells Via miR-1-3p/ADAM10 Axis in Thoracic Aortic Aneurysm

Comparison of TGF-β1 distribution and expression in aortic wall of thoracic aortic dissection versus aneurysm

A decrease in integrin α5β1/FAK is associated with increased apoptosis of aortic smooth muscle cells in acute type a aortic dissection

Angiocrine FSTL1 (Follistatin-Like Protein 1) Insufficiency Leads to Atrial and Venous Wall Fibrosis Via SMAD3 Activation

Abstract 9816: Clinical and Pathophysiological Relevance of Follistatin-Like 1 in Calcific Aortic Valve Disease

Single-Cell Transcriptome Analysis Reveals Dynamic Cell Populations and Differential Gene Expression Patterns in Control and Aneurysmal Human Aortic Tissue

Identification and Characterization of CD4(+)AT2(+) T Lymphocyte Population in Human Thoracic Aortic Aneurysm.

Abstract 468: HIF-1α Mediates Initiation and Progression of Experimental Abdominal Aortic Aneurysms

Unraveling the role of the FHL family in cardiac diseases: Mechanisms, implications, and future directions

Angiocrine FSTL1 Insufficiency Leads to Atrial and Vein Wall Fibrosis Via SMAD3 Activation

FHL2 is a novel target in pulmonary arterial hypertension